The mouse adipsin gene encodes a member of the serine protease family that is expressed predominantly in adipose tissue and is secreted into the bloodstream. Adipsin expression is sharply down-regulated in several models of genetic and acquired obesity, representing the first example of an adipocyte gene whose expression is greatly altered in this disorder. In this study, we have asked whether a DNA fragment from the adipsin gene can direct tissue-specific expression of a heterologous gene and mediate the suppression of this expression in genetic and chemically induced obesity. Transgenic mice have been constructed with 950 bases of DNA from the 5' flanking region of the adipsin gene linked to the bacterial chloramphenicol acetyltransferase (CAT) gene in a mouse strain bearing a recessive obesity gene (diabetes, db). By crossing db/+ transgenic mice with nontransgenic db/+ mice, we obtained progeny that allowed a direct comparison of CAT expression in the tissues of lean and obese littermates. The lean mice express CAT activity predominantly in adipose tissue, while the obese mice show a marked reduction in CAT expression relative to the lean controls. When similar experiments are performed with an adipsin-CAT fusion gene containing a heterologous AKV (AKR mouse leukemia virus) enhancer, the tissue specificity of CAT expression in lean mice is broadened to include the thymus, spleen, brain, and other tissues; downregulation occurs in all of these tissues in mice homozygous for the obesity gene or in mice that have been injected with monosodium glutamate (MSG), which induces obesity. These results indicate that 950 bases of the 5' flanking region of the adipsin gene carry information that specifies both expression in adipose tissue and a response to a gene or chemical that induces obesity. These results also suggest that the trans-acting factors that are regulated aberrantly in these forms of obesity are not restricted to adipose tissue and could play a role in obesitylinked dysfunctions observed in other tissues as well.
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Obesity is a heterogeneous disorder characterized by an excessive mass of adipose tissue. This disease arises through an increased number of adipocytes or an excessive lipid accumulation per cell or both. Obesity makes a major contribution to morbidity and mortality in the industrialized world, primarily through associated cardiovascular disorders and obesity-linked diabetes.
Many studies of obesity have been directed toward the adipocyte. This cell functions to store energy in times of nutritional abundance and releases this energy in a biochemically useful form during nutritional deprivation. Adipocytes activate a very distinctive program of gene expression upon differentiation from fibroblastic precursor cells (1, 2) . Many ofthe genes whose expression increases greatly upon adipose differentiation encode key enzymes in triglyceride metabolism such as glycerophosphate dehydrogenase, malic enzyme, and fatty acid synthetase (3) . In addition, a number of other proteins are expressed, whose functions are poorly understood at present. These include the lipid-binding protein adipocyte P2 (designated aP2) (4-7), the serine protease adipsin (8) , and a new cytochrome P-450-like molecule (G. M. Ringold, personal communication).
It is commonly assumed that the regulation of adipocyte gene expression by hormones and other neuroendocrine factors plays a crucial role in obesity because there is improper control of lipogenesis and lipolysis in this disease. We recently performed a study of the expression of three fat cell genes in lean and obese rodents and observed the first striking changes in adipocyte gene expression correlating with this disorder. While the levels of mRNA for glycerophosphate dehydrogenase and aP2 were essentially identical in lean and obese groups, the expression of adipsin mRNA was sharply reduced (99%) in the adipose tissue of obese animals (9) . This was true in two forms of genetic obesity in the mouse (ob/ob and db/db) and in obesity resulting from the injection of monosodium glutamate (MSG). No change in adipsin mRNA was observed in obesity resulting from pure overfeeding (the cafeteria-fed rat). Reductions in adipsin expression were also observed in the genetically obese fa/fa rat (ref. 9 ; P. Johnson, B. Rosen, B.M.S., and M. R. C. Greenwood, unpublished observations). The fact that adipsin is secreted into the blood suggests that the protein could play a systemic role in lipid metabolism or other physiological systems relating to energy balance (10) . Recent studies with purified adipsin have indicated that it has a catalytic activity identical to human complement factor D and factor D deficiencies are seen in several models of obesity (11) .
The mechanisms by which an obesity gene may regulate the expression of other genes are completely unknown. The adipsin gene (chromosome 10; ref. 12 ) is asyntenic with the db (chromosome 4) or ob (chromosome 6) loci, so the lower level of adipsin in these obese animals must reflect a regulatory defect rather than a direct genetic lesion. Since cultured adipose cell lines from the ob/ob mouse appear to express adipsin mRNA quite normally during cell differentiation (13) , it is necessary to study this regulatory defect in the intact animal. To study the regulation of adipsin expression in normal and obese mice, we 
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obesity gene or to the effects of MSG-injection can occur in numerous tissues in addition to adipose tissue.
MATERIALS AND METHODS
Construction of Transgenic Mice. Both constructs, adn-(-)CAT and adn(+)CAT, were isolated away from plasmid sequences as described (14) and injected into the nuclei of one-cell embryos derived from a cross between C57BL/KsJ and db+/+m parents (The Jackson Laboratory). Homozygous lean (+m/+m) animals were identified by the misty (m) coat color, whereas heterozygous lean (db+/+m) and homozygous obese (db+/db+) littermates were distinguished both phenotypically and by measurement of the ability of the animals to thermoregulate in response to cold (15, 16) . We also made transgenic mice with the adn(+)CAT construct in an inbred congenic resistant (ICR) (Charles River Breeding Laboratories) background in order to carry out the MSGinduced obesity experiments described below. Transgenic animals were identified by Southern blot analysis of tail DNA as described (14) .
CAT Assays. Tissue extracts were prepared by homogenization and sonication, followed by heating at 65°C for 15 min. The extracts were centrifuged, and the supernatants were used for CAT assays (17) . Protein concentrations were determined by the Bio-Rad colorimetric method (Bio-Rad). After thin-layer chromatography, both the acetylated and unconverted chloramphenicol spots were cut out and assayed, and specific activities were determined (cpm/mg of protein per min of reaction time).
RESULTS
Two constructs were used to make transgenic mice. The first construct contained positions -950 to +35 of the mouse adipsin gene linked to the bacterial CAT gene coding sequences and simian virus 40 (SV40) polyadenylylation signal without the addition of a heterologous enhancer [termed adn(-)CAT; Fig. 1 ]. Because we had previously found that the adn(-)CAT construct is expressed weakly after transfection into cultured adipocytes, we also used a second construct containing a 333-bp fragment of the AKR 614 virus enhancer (19) downstream from the SV40 small tumor antigen splice and polyadenylylation sequences [adn(+)CAT; (18), containing from -950 to +35 relative to the transcription start site of the adipsin promoter linked to the bacterial CAT gene and containing the SV40 small tumor antigen intron and polyadenylylation signal sequence was used to make adn(-)CAT mice. To make the adn(+)CAT mice, a 4.8-kilobase Nde I-Pvu I fragment, containing the same adipsin, CAT, and SV40 small tumor antigen sequences as in adn(-)CAT but including a 650-bp sequence containing the AKV enhancer downstream of the CAT sequences, was injected into zygotes.
the enhancerless construct [adn(-)CAT] which had detectable CAT activity (Table 1) . In both cases, this gene was expressed in adipose tissue but not in any offour other tissues examined in these founders. Since obese (db/db) mice are sterile, only the heterozygous db/+ adn(-)CAT-3 strain could be propagated. The adn(-)CAT-3 female was mated to a nontransgenic db+ /+m male, and offspring of the expected genotypes were produced. When various tissues were analyzed for CAT activity, expression was detectable only in adipose tissue in transgenic, lean (db+/+m) offspring (Table  2) . Thus, the region from -950 to +35 of the adipsin gene appears to be sufficient to direct expression of the reporter gene specifically to adipose tissue.
The effect of the db locus on the expression derived from the adipsin promoter can be examined by comparison of the lean and obese offspring in this strain. Table 2 shows that the level of expression of CAT activity in the adipose tissue of a lean mouse was at least 14 times higher than that observed in an obese, sex-matched littermate. This striking difference in expression was observed in a total of six mice examined, three lean and three obese. These data indicate that the Fig. 2 ). CAT activity was also observed in brown fat (Fig. 2) , but since contamination with white fat is likely (especially in the obese animals), the significance of this result is uncertain. Nevertheless, it is clear that the AKV enhancer has the effect of broadening the tissue distribution of expression driven by the adipsin promoter.
This broadened tissue distribution allowed us to examine whether the effect ofthe obesity gene on the adipsin promoter was limited to adipose tissue. Table 2 and Fig. 2 show that a sharp reduction in CAT activity was observed in all tissues expressing this gene in the db/db mice compared to their lean db/+ siblings (two obese and numerous lean mice have been examined). Therefore, it appears that the pathway of signal transduction from the db gene to the adipsin promoter is not limited to fat tissue but exists in many cell types.
Another form of obesity in which there is aberrant adipsin expression (9) is MSG-induced obesity (20, 21) . To see if treatment of mice with this agent would also alter the levels of transgene expression, we used the offspring of an ICR strain adn(+)CAT-5 founder mouse (Table 1) . This founder was mated to a nontransgenic ICR male, and several litters of offspring were produced. Half of each litter was injected for the first 7 days of life with MSG (3 mg/g of body weight). This treatment results in a 3-fold increase in adipose mass relative to normal animals by the age of 2 months and a 95% decrease in endogenous adipsin mRNA levels by the age of5 weeks (9) . As can be seen in Table 2 , CAT expression in fat tissue and in the thymus is sharply reduced in the MSG-treated transgenic animals compared with their untreated transgenic siblings. To control for the possibility that MSG injection itself might affect CAT activity nonspecifically, we studied mice that contained a transgene consisting of a short fragment (-268 to +21) of a promoter from a different adipocyte gene, aP2, linked to CAT. This transgene resulted in CAT activity in adipose and several other tissues (including thymus), but the activity was unaffected by MSG injections (not shown). (24) . Similarly, expression of adipsin mRNA is defective in ob/ob fat cells in vivo but appears to be quite normal in cultured adipocyte cell lines derive from ob/ob mice (13) . Together these data suggest that meaningful results concerning aberrant gene regulation in obesity will probably require in vivo studies, for which transgenic mice will be very useful.
The results presented in this study allow us to conclude that approximately 950 bp of the 5' portion of the adipsin gene are sufficient to both direct CAT expression to adipose tissue and to modulate this expression in genetic (db/db) and MSGinduced obesity. Whether or not a heterologous enhancer is used in the adipsin constructions, the magnitude of the reduction in CAT activity in response to the obesity gene and MSG injection is large (at least 90%o suppression). We cannot say with certainty whether the changes observed in the level of the CAT enzyme activity correspond fully to the decreases seen in the endogenous adipsin mRNA levels (95-99% suppression) in these obese mice (9) . However, it is likely that the promoterrelated effect shown here is a major contributor to the reductions seen in adipsin mRNA in obese mice.
The heterologous enhancer used in some transgenic strains appears to influence the range of tissue expression directed by the adipsin promoter fragment. Of all the tissues of adn(+)CAT transgenic mice in which we detect CAT activity, only adipose tissue contains appreciable amounts of endogenous adipsin RNA (not shown). The presence of the AKV enhancer in the adn(+)CAT transgene apparently alters the tissue specificity directed by the adipsin 5' sequences, in that high levels of expression are also seen in thymus and lower but significant levels are seen in other tissues. AKV is a T-cell leukemia virus, so that it is not surprising that transgenic mice containing the adn(+)CAT transgene frequently express in lymphoid tissue in addition to adipose tissue; the viral enhancer has also been shown to function in several cell types in tissue culture transfection experiments (19, 25 
